Join our community of smart investors

EKF gets US okay

The final piece in a jigsaw means EKF can make an impact in the US
March 8, 2012

Diagnostics business EKF has been granted a patent in the US for the cuvettes used by its HemoPoint H2 hemoglobin testing kits.

IC TIP: Buy at 24.25p

This complements the waiver received for the HemoPoint kit last year and allows US distribution partner Alere to press on with selling into this potentially-huge market.